Intercure director discloses existing option holdings

Intercure Ltd. director David Salton filed an initial Form 3 detailing his existing option holdings, rather than new trades.

Rhea-AI Filing Summary

Intercure Ltd. director David Salton filed an initial Form 3 detailing his existing option holdings, rather than new trades. He reports share options over 4,046 ordinary shares with a converted exercise price of $8.22 per share, expiring on January 9, 2030; these options were granted in 2020 and became fully vested on January 9, 2023. He also reports share options over 15,000 ordinary shares with a converted exercise price of $3.10 per share, expiring on September 5, 2028, which were granted on September 5, 2024 and vest quarterly over four years.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Salton David

Role Director

Type	Security	Shares	Price	Value
holding	Share options (right to buy)	--	--	--
holding	Share options (right to buy)	--	--	--

Holdings After Transaction: Share options (right to buy) — 19,046 contracts (Direct)

Footnotes (2)

1. F1. The options were granted on January 9, 2020, and the current exercise price is NIS 25.146 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.06 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $8.22 per share. The options became fully vested as of January 9, 2023.
2. F2. The options were granted on September 5, 2024 and the current exercise price is NIS 9.50 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.06 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $3.10 per share. The options vest on a quarterly basis over four years from the date of grant.

Key Figures

Underlying shares (2020 grant): 4,046 shares Exercise price (2020 options): $8.22 per share Expiration (2020 options): January 9, 2030 +5 more

8 metrics

Underlying shares (2020 grant) 4,046 shares Share options over ordinary shares from January 9, 2020 grant

Exercise price (2020 options) $8.22 per share Converted from NIS 25.146 using 3.06 NIS/USD as of April 14, 2026

Expiration (2020 options) January 9, 2030 Expiry date for options over 4,046 ordinary shares

Underlying shares (2024 grant) 15,000 shares Share options over ordinary shares from September 5, 2024 grant

Exercise price (2024 options) $3.10 per share Converted from NIS 9.50 using 3.06 NIS/USD as of April 14, 2026

Expiration (2024 options) September 5, 2028 Expiry date for options over 15,000 ordinary shares

Vesting status (2020 options) Fully vested Became fully vested on January 9, 2023

Vesting schedule (2024 options) Quarterly over four years From September 5, 2024 grant date

Key Terms

Share options (right to buy), exercise price, underlying security, vested, +1 more

5 terms

Share options (right to buy) financial

"security_title: "Share options (right to buy)""

exercise price financial

"the current exercise price is NIS 25.146 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

underlying security financial

"underlying_security_title: "Ordinary Shares""

vested financial

"The options became fully vested as of January 9, 2023"

Form 3 regulatory

"For purposes of this Form 3, the exercise price has been converted"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Intercure Ltd. (INCR) Form 3 filing by David Salton show?

The Form 3 shows director David Salton’s existing option holdings in Intercure Ltd., including options over 4,046 shares at $8.22 and 15,000 shares at $3.10. It reports positions only, without indicating recent purchases or sales.

How many Intercure Ltd. (INCR) shares are covered by David Salton’s options?

David Salton reports share options over 4,046 ordinary shares from a 2020 grant and 15,000 ordinary shares from a 2024 grant. These figures represent the underlying ordinary shares that may be acquired upon exercising the options, subject to vesting and expiration terms.

What are the exercise prices of David Salton’s Intercure Ltd. (INCR) options?

The filing states converted exercise prices of $8.22 per share for options over 4,046 shares and $3.10 per share for options over 15,000 shares. These amounts are translated from NIS using a 3.06 NIS to $1.00 exchange rate as of April 14, 2026.

When do David Salton’s Intercure Ltd. (INCR) options vest and expire?

Options over 4,046 shares fully vested on January 9, 2023 and expire on January 9, 2030. Options over 15,000 shares were granted September 5, 2024, vest quarterly over four years, and expire on September 5, 2028, according to the disclosure.

Does the Intercure Ltd. (INCR) Form 3 indicate that David Salton bought or sold shares?

No. The Form 3 presents holdings of share options, not open-market trades. The transactions are categorized as holdings with unknown transaction codes, and the summary shows zero buy or sell counts, indicating no reported purchases or sales in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/16/2026 - 04:01 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Salton David

(Last) (First) (Middle)

85 MEDINAT HA-YEHUDIM STREET

(Street)

HERZLIYA 4676670

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Intercure Ltd. [ INCR ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share options (right to buy)(1)	03/31/2020	01/09/2030	Ordinary Shares	4,046	$8.22	D
Share options (right to buy)(2)	09/30/2024	09/05/2028	Ordinary Shares	15,000	$3.1	D

Explanation of Responses:

1. The options were granted on January 9, 2020, and the current exercise price is NIS 25.146 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.06 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $8.22 per share. The options became fully vested as of January 9, 2023.

2. The options were granted on September 5, 2024 and the current exercise price is NIS 9.50 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.06 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $3.10 per share. The options vest on a quarterly basis over four years from the date of grant.

	/s/ David Salton	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)